News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,624 Results
Type
Article (40714)
Company Profile (276)
Press Release (659634)
Section
Business (206240)
Career Advice (2009)
Deals (35725)
Drug Delivery (95)
Drug Development (82278)
Employer Resources (169)
FDA (16294)
Job Trends (14983)
News (348788)
Policy (32737)
Tag
Academia (2575)
Alliances (50118)
Alzheimer's disease (1320)
Approvals (16278)
Artificial intelligence (212)
Bankruptcy (358)
Best Places to Work (11774)
Biotechnology (200)
Breast cancer (234)
Cancer (1801)
Cardiovascular disease (128)
Career advice (1671)
CAR-T (131)
Cell therapy (371)
Clinical research (66329)
Collaboration (685)
Compensation (379)
COVID-19 (2578)
C-suite (167)
Data (1655)
Diabetes (214)
Diagnostics (6363)
Earnings (86022)
Employer resources (145)
Events (112831)
Executive appointments (577)
FDA (17224)
Funding (611)
Gene therapy (250)
GLP-1 (659)
Government (4388)
Healthcare (19011)
Infectious disease (2693)
Inflammatory bowel disease (125)
Interviews (310)
IPO (16591)
Job creations (3654)
Job search strategy (1424)
Layoffs (456)
Legal (7918)
Lung cancer (270)
Manufacturing (239)
Medical device (13315)
Medtech (13320)
Mergers & acquisitions (19515)
Metabolic disorders (556)
Neuroscience (1731)
NextGen: Class of 2025 (6575)
Non-profit (4510)
Northern California (2123)
Obesity (312)
Opinion (201)
Patents (167)
People (57551)
Phase I (20717)
Phase II (29207)
Phase III (21764)
Pipeline (734)
Postmarket research (2593)
Preclinical (8710)
Radiopharmaceuticals (253)
Rare diseases (325)
Real estate (5957)
Regulatory (22157)
Research institute (2361)
Resumes & cover letters (349)
Southern California (1825)
Startups (3634)
United States (18826)
Vaccines (623)
Weight loss (212)
Date
Today (161)
Last 7 days (755)
Last 30 days (2725)
Last 365 days (34946)
2025 (4776)
2024 (35676)
2023 (40498)
2022 (51695)
2021 (56233)
2020 (54539)
2019 (47056)
2018 (35455)
2017 (32656)
2016 (32027)
2015 (38064)
2014 (31749)
2013 (26719)
2012 (28926)
2011 (29660)
2010 (27609)
Location
Africa (725)
Arizona (211)
Asia (38274)
Australia (6259)
California (4861)
Canada (1728)
China (408)
Colorado (219)
Connecticut (232)
Europe (83054)
Florida (702)
Georgia (165)
Illinois (464)
Indiana (261)
Maryland (753)
Massachusetts (3742)
Michigan (198)
Minnesota (341)
New Jersey (1368)
New York (1384)
North Carolina (849)
Northern California (2123)
Ohio (174)
Pennsylvania (1115)
South America (1105)
Southern California (1825)
Texas (708)
Utah (147)
Washington State (472)
700,624 Results for "curelab oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
CureLab Oncology Files Patent Application for Groundbreaking Wound-Healing Therapy
CureLab Oncology, a clinical-stage biotech company, has filed a patent application with worldwide potential for a revolutionary wound-healing therapy based on its p62/SQSTM1 DNA plasmid.
June 27, 2024
·
2 min read
Press Releases
CureLab Oncology Appoints Dr. Aubrey C. Galloway as Chief Medical Officer
July 11, 2024
·
3 min read
Genetown
CureLab Receives $3M from Prominent Biotech Investor Dr. John Ballantyne
The co-founder of Aldevron, Dr. John Ballantyne, has invested $3M in CureLab Oncology and CureLab Veterinary.
March 2, 2023
·
3 min read
Collaboration
Incyte Backs Out of Immuno-Oncology Pact With Agenus
The partnership dates back to 2015, when Incyte paid $60 million upfront for access to four checkpoint programs, including TIM-3, LAG-3, OX40 and GITR.
February 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
February 17, 2025
·
11 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
November 25, 2024
·
7 min read
Press Releases
Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
December 29, 2024
·
11 min read
Press Releases
Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting
January 13, 2025
·
3 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
December 17, 2024
·
6 min read
Press Releases
Taiho Oncology Announces Decitabine and Cedazuridine to be Included in NIH Precision Medicine Trials
January 15, 2025
·
3 min read
1 of 70,063
Next
